Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166128215> ?p ?o ?g. }
- W3166128215 endingPage "2987" @default.
- W3166128215 startingPage "2987" @default.
- W3166128215 abstract "Although EGFR-TKI treatment of NSCLC (non-small-cell lung cancer) patients often achieves profound initial responses, the efficacy is transient due to acquired resistance. Multiple receptor tyrosine kinase (RTK) pathways contribute to the resistance of NSCLC to first- and third-generation EGFR-TKIs, such as erlotinib and osimertinib. To identify potential targets for overcoming EGFR-TKI resistance, we performed a gene expression signature-based strategy using connectivity map (CMap) analysis. We generated erlotinib-resistant HCC827-ErlR cells, which showed resistance to erlotinib, gefitinib, osimertinib, and doxorubicin. A list of differentially expressed genes (DEGs) in HCC827-ErlR cells was generated and queried using CMap analysis. Analysis of the top 4 compounds from the CMap list suggested HSF1 as a potential target to overcome EGFR-TKI resistance. HSF1 inhibition by using HSF1 shRNAs or KRIBB11 decreased the expression of HSF1 downstream proteins, such as HSP70 and HSP27, and also decreased the expression of HSP90/HSP70/BAG3 client proteins, such as BCL2, MCL1, EGFR, MET, and AXL, causing apoptosis of EGFR-TKI-resistant cancer cells. Finally, we demonstrated the efficacy of the HSF1 inhibitor on PC9-ErlR cells expressing mutant EGFR (T790M) in vivo. Collectively, these findings support a targetable HSF1-(HSP90/HSP70/BAG3)-(BCL2/MCL1/EGFR/MET/AXL) pathway to overcome multiple mechanisms of EGFR-TKI resistance." @default.
- W3166128215 created "2021-06-22" @default.
- W3166128215 creator A5011376267 @default.
- W3166128215 creator A5026224502 @default.
- W3166128215 creator A5029756043 @default.
- W3166128215 creator A5046050915 @default.
- W3166128215 creator A5059886217 @default.
- W3166128215 creator A5062979923 @default.
- W3166128215 creator A5065271933 @default.
- W3166128215 creator A5080967808 @default.
- W3166128215 creator A5087350067 @default.
- W3166128215 date "2021-06-15" @default.
- W3166128215 modified "2023-10-01" @default.
- W3166128215 title "Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer" @default.
- W3166128215 cites W1526983978 @default.
- W3166128215 cites W1546552389 @default.
- W3166128215 cites W1563968398 @default.
- W3166128215 cites W1585804517 @default.
- W3166128215 cites W1842992197 @default.
- W3166128215 cites W1858596856 @default.
- W3166128215 cites W1977443669 @default.
- W3166128215 cites W1977540908 @default.
- W3166128215 cites W1979975605 @default.
- W3166128215 cites W1983159571 @default.
- W3166128215 cites W1990013637 @default.
- W3166128215 cites W1994061224 @default.
- W3166128215 cites W2015498372 @default.
- W3166128215 cites W2031143435 @default.
- W3166128215 cites W2037250030 @default.
- W3166128215 cites W2042699875 @default.
- W3166128215 cites W2049321389 @default.
- W3166128215 cites W2049776490 @default.
- W3166128215 cites W2056218982 @default.
- W3166128215 cites W2059524588 @default.
- W3166128215 cites W2075341017 @default.
- W3166128215 cites W2076178766 @default.
- W3166128215 cites W2088942787 @default.
- W3166128215 cites W2093613683 @default.
- W3166128215 cites W2110211370 @default.
- W3166128215 cites W2111662961 @default.
- W3166128215 cites W2121604817 @default.
- W3166128215 cites W2125974203 @default.
- W3166128215 cites W2126177831 @default.
- W3166128215 cites W2132870547 @default.
- W3166128215 cites W2133555426 @default.
- W3166128215 cites W2138893834 @default.
- W3166128215 cites W2139236349 @default.
- W3166128215 cites W2139843511 @default.
- W3166128215 cites W2141322853 @default.
- W3166128215 cites W2144950416 @default.
- W3166128215 cites W2152622809 @default.
- W3166128215 cites W2153475997 @default.
- W3166128215 cites W2157360354 @default.
- W3166128215 cites W2159443208 @default.
- W3166128215 cites W2162092051 @default.
- W3166128215 cites W2166084034 @default.
- W3166128215 cites W2169058508 @default.
- W3166128215 cites W2169105660 @default.
- W3166128215 cites W2170573493 @default.
- W3166128215 cites W2319589010 @default.
- W3166128215 cites W2416111151 @default.
- W3166128215 cites W2462847503 @default.
- W3166128215 cites W2471550966 @default.
- W3166128215 cites W2560717039 @default.
- W3166128215 cites W2606001457 @default.
- W3166128215 cites W2612467560 @default.
- W3166128215 cites W2753184893 @default.
- W3166128215 cites W2760639821 @default.
- W3166128215 cites W2766316939 @default.
- W3166128215 cites W2770828094 @default.
- W3166128215 cites W2790922923 @default.
- W3166128215 cites W2792821195 @default.
- W3166128215 cites W2794026637 @default.
- W3166128215 cites W2808586822 @default.
- W3166128215 cites W2889646458 @default.
- W3166128215 cites W2896002881 @default.
- W3166128215 cites W2902774017 @default.
- W3166128215 cites W2905010694 @default.
- W3166128215 cites W2913651890 @default.
- W3166128215 cites W3121220693 @default.
- W3166128215 cites W4247507498 @default.
- W3166128215 doi "https://doi.org/10.3390/cancers13122987" @default.
- W3166128215 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8232331" @default.
- W3166128215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34203709" @default.
- W3166128215 hasPublicationYear "2021" @default.
- W3166128215 type Work @default.
- W3166128215 sameAs 3166128215 @default.
- W3166128215 citedByCount "7" @default.
- W3166128215 countsByYear W31661282152022 @default.
- W3166128215 countsByYear W31661282152023 @default.
- W3166128215 crossrefType "journal-article" @default.
- W3166128215 hasAuthorship W3166128215A5011376267 @default.
- W3166128215 hasAuthorship W3166128215A5026224502 @default.
- W3166128215 hasAuthorship W3166128215A5029756043 @default.
- W3166128215 hasAuthorship W3166128215A5046050915 @default.
- W3166128215 hasAuthorship W3166128215A5059886217 @default.
- W3166128215 hasAuthorship W3166128215A5062979923 @default.
- W3166128215 hasAuthorship W3166128215A5065271933 @default.